Tioguanine Production Cost Reports

The report provides a detailed analysis essential for establishing a Tioguanine production plant. It encompasses all critical aspects necessary for Tioguanine production, including the cost of Tioguanine production, Tioguanine plant cost, Tioguanine production costs, and the overall Tioguanine production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Tioguanine production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Thioguanine is an oral chemotherapy medicine that works as a simulated building block for DNA and RNA in fast-growing cancer cells. It stops their growth and division during their replication phase. It is FDA-approved to help induce remission or maintain control in acute myeloid leukaemia. It is also used in acute lymphoblastic leukaemia in children and adults, or chronic myeloid leukaemia, as part of combination drug regimens.

Its treatment starts at a dose of 2 mg per kg of body weight taken daily by mouth, with adjustments made based on regular blood tests to monitor white cells, red cells, and platelets. Also, genetic testing is done before to prevent severe side effects like bone marrow suppression. It is also used for non-cancer conditions like inflammatory bowel diseases (like ulcerative colitis), psoriasis, or even celiac disease as an immunosuppressant, but the risks of liver damage, like veno-occlusive disease, require close monitoring.

The market for Thioguanine is influenced by rising leukaemia incidence and early cancer diagnosis.Its usage in treating acute lymphoblastic leukaemia and chronic myeloid leukaemia boosts its market. Its utilisation in non-cancer conditions like inflammatory bowel diseases further contributes to its market growth.

Factors like tenders and rate contracts for hospital purchases and limited supplier pools in pediatric oncology affect industrial Thioguanine procurement. Other factors, like frequent stockouts from limited suppliers and poor planning in pediatric cancer programs, expose hospitals to shortages and spikes that affect their market dynamics. Also, combining pooled procurement groups like PAHO helps secure better pricing and quality, unlike separate centres that pay more and risk unreliable supply.

Raw Material for Tioguanine Production

According to the Tioguanine production plant project report, the key raw materials used in the production of Tioguanine include 2,9-Diacetylguanine-Phosphorus Pentasulfide-Pyridine-Pyridine Hydrochloride.

Production Process of Tioguanine

The extensive Tioguanine production cost report consists of the following major industrial production process:

1. By the Thiation process: The production process of Tioguanine involves a one-step thiation method.  In this process, 2,9-diacetylguanine reacts with phosphorus pentasulfide in pyridine solvent under mild conditions. To this, a small amount of organic amine salt catalyst, like pyridine hydrochloride, is also added. After reaction, pyridine is removed, and the product goes through crystallisation, filtered to get the crude product. This was further refined with dilute ammonia (decolourised), pH adjusted to 4 with acetic acid, and crystallised to yield pure Tioguanine.

Tioguanine is a pale yellow to light orange, odourless crystalline powder. It has the molecular formula of C5H5N5S and a molecular weight of 167.19 g/mol. Its logP is -0.07, which makes it hydrophilic, and collision cross sections around 128.9–142.3 Å. It has a melting point greater than 360 degree Celsius and is insoluble in water and organic solvents like ethanol/acetone but soluble in alkali hydroxides. It appears as a solid stable at room temperature (ideally <15 degree Celsius). It acts as a prodrug converted intracellularly by HGPRT to cytotoxic thioguanine nucleotides that incorporate into DNA/RNA, stopping synthesis and function.